"Surprised this has not been discussed here
"Biotechnology giant CSL (ASX: CSL) is set to expand its portfolio of vaccines with a company-backed start up raising $14 million in capital, mostly from a federal government fund."
You're surprised that no one has commented on a company capitalised at over $100 billion getting involved in some kind of a relationship with a company capitalised at $14 million?
Frankly, given the irrelevance in terms of immateriality, I'm surprised anyone would consider it to be mention-worthy at all.
(Why, the contract to manage the indoor plants in CSL's various offices around the world, or its tea & biscuit budget, are probably of the order of magnitude of $14m...)
Dental caries vaccine, page-2
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$299.60 |
Change
-1.600(0.53%) |
Mkt cap ! $145.0B | |||
| Open | High | Low | Value | Volume |
| $300.91 | $301.16 | $298.02 | $174.8M | 583.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2000 | $299.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $299.69 | 766 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |